Loading
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Feb 2026 for Veradermics, Inc, €290k. Read the official filing
Filing timeline
BuySaleSuvretta Capital Management, LLC
Insider track record
Disclosed buys
10
Disclosed sells
0
Signal history
Closed purchases
Market purchases
10
Positive at T+90
40%
Median T+90
-6.6%
Based on 10 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +179.1%Entry US$40.45 · Close 07 Oct 2026 US$112.89
- -27.8%Entry US$13.93 · Close at T+90 US$10.06
- -13.7%Entry US$12.96 · Close at T+90 US$11.19
- -11.1%Entry US$13.26 · Close at T+90 US$11.79
- -15.5%Entry US$13.01 · Close at T+365 US$10.99
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Suvretta Capital Management, LLC: trading record in brief
Filings by Suvretta Capital Management, LLC span 2 companies, the busiest being Benitec Biopharma Inc. and Veradermics, Inc. We count 11 filings; the first trade dates from 26 September 2024 and the latest from 4 February 2026.
No open-market sale appears; the market trades are 10 purchases worth €28.5M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Outside the open market, there are 1 share grant. In 2026 alone, the filings show 1 purchase and no sales.
The median purchase comes to €315k. No cluster: in 10 purchases, no other insider of the company bought within 30 days. For 10 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 40% of cases, with a median move of -6.6%. Past outcomes like these are no guarantee of what comes next.
Most recently, on 9 February 2026, the filings show an open-market purchase worth €290k in Veradermics, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Suvretta Capital Management, LLC
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
10,004 shares@ US$34.25100.0% of flowCommon stock, par value $0.00001 per shareSEC:0000899140-26-000140:0
Canonical exit: 5 May 2026 (T+90)
42,600 shares@ US$12.851.6% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-25-001479:0
Canonical exit: 23 Mar 2026 (T+90)
8,700 shares@ US$11.240.3% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-25-001459:0
Canonical exit: 18 Mar 2026 (T+90)
730,370 shares@ US$13.5029.2% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-25-001256:0
Canonical exit: 5 Feb 2026 (T+90)
751,111 shares@ US$13.5030.0% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-25-001256:1
Canonical exit: 5 Feb 2026 (T+90)
9,503 shares@ US$12.630.4% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-25-000486:0
Canonical exit: 29 Jun 2025 (T+90)
793,800 shares@ US$13.0032.7% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-25-000479:0
Canonical exit: 24 Jun 2025 (T+90)
24,360 shares@ US$10.980.9% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-24-001385:0
Canonical exit: 23 Mar 2025 (T+90)
37,190 shares@ US$9.601.2% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-24-001318:0
Canonical exit: 3 Mar 2025 (T+90)
12,430 shares@ US$9.730.4% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-24-001299:0
Canonical exit: 17 Feb 2025 (T+90)
588,236 shares@ US$1.92993.5% of flowCommon stock, par value $0.0001 per shareSEC:0000899140-24-001042:0
11 of 11 declarations
